BRIEF-DBV Technologies receives FDA breakthrough therapy designation for Viaskin peanut
April 09, 2015 at 01:12 AM EDT
* Receives FDA breakthrough therapy designation for Viaskin peanut for the treatment of peanut allergy in children
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|